Published: Apr, 2018
The global cell culture market was valued at around US$ 13,000.0 Mn in 2016 and is anticipated to register a stable CAGR of over 9.5% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The global cell culture market is likely to be driven by development of new products, technological advancements, and increasing use of single-use bioprocessing systems during the forecast period. The cell culture market in Asia Pacific is expanding at a CAGR of above 10.0%, due to high unmet clinical needs, development of the health care sector, and increased focus on R&D activities in the region.
Increasing Demand and Approvals for Biosimilar Products and Other Biologic Therapeutics to drive the Market
Cell culture is one of the most important steps in the production of biosimilar antibodies, as cell culture helps increase the efficiency and productivity and reduces the cost of manufacture. Increasing demand and approvals for biosimilar products and other biologic therapeutics for the treatment of chronic diseases in developed as well as developing countries has augmented the demand for efficient and cost-effective products. This rising demand is, in turn, anticipated to drive the global cell culture market during the forecast period. Moreover, increasing demand for cost-effective and highly efficient cell culture products such as bioreactors, mediums, reagents, and sera for the production of high-yield cell lines has led to increase in the number of new product launches. This factor is anticipated to provide lucrative opportunities to the global cell culture market during the forecast period. Major manufactures are constantly trying to expand their product portfolio by launching new and advanced systems for large-scale production which is cost-effective and which involves low risk of contamination. For instance, in 2018, Merck launched capsule filters that are designed to decrease the risk of contamination in a bioreactor. These filters are used for separation of mycoplasma and bacteria from cell culture mediums. However, ethical issues associated with the use of fetal bovine serum, stringent regulations, and high cost of infrastructure required for cell culture are expected to hamper the global cell culture market during the forecast period.
Technological Advancements in Cell Culture Production Mediums and Instruments are likely to fuel the Demand for Protein-based Therapeutics
Based on product, the global cell culture market has been categorized into instruments, mediums, sera, and reagents. The instruments segment has been sub-categorized into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. Technological advancements for improving the efficiency and reducing the risk of cross contamination are expected to drive the instruments segment during the forecast period. The mediums segment has been sub-segmented into chemically defined mediums, classical mediums, protein-free mediums, lysogeny broths, serum-free mediums, and specialty mediums. High efficiency of different mediums used for cell culture production is anticipated to drive the mediums segment during the forecast period. The sera segment has been sub-divided into fetal bovine serum and others. Sera are used as cell culture supplements consisting of growth factors, nutrients, and other important trace elements. The reagents segment has been sub-categorized into albumin, amino acids, attachment factors, growth factors & cytokines, protease inhibitors, thrombin, and others. Applications such as stem cell research offer high potential for growth of the cell culture market in the near future. Stem cell culture assists in the standardization of drug production and enables production of a wide variety of cell lines and related products. Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Thus, further research in the field of stem cell culture for the development of drugs offers high potential for the market in the near future.
Increasing Research and Development Expenditure to fuel Pharmaceutical Companies Segment
In terms of end-user, the global cell culture market has been divided into biotechnology companies, pharmaceutical companies, academic institutes, and research institutes. The pharmaceutical companies segment dominated the cell culture market in 2016. The trend is anticipated to continue during the forecast period as well. The segment is expected to hold more than 29.0% of the market share by 2025. Growth of the segment is attributable to increasing number of biotechnology companies and rising strategic collaborations among market players to expand the presence worldwide. The pharmaceutical companies segment is likely to be followed by the biotechnology companies segment during the forecast period.
Increasing Focus of Key Players in Asia Pacific on Creation of more Opportunities for Cell Culture Market
Geographically, the global cell culture market has been divided into major five geographical regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major share of the market during the forecast period, owing to presence of key players in the region, increasing research and development activities, and new drug approvals. Shift in trend toward continuous processing is also anticipated to drive the cell culture market in North America from 2017 to 2025. The Asia Pacific cell culture market was valued at around US$ 2,900.0 Mn in 2016 and is anticipated to witness significant growth from 2017 to 2025. Increasing focus of key players on expansion in the Asia Pacific region, large untapped population, and rising awareness about health care promote the growth of the cell culture market in Asia Pacific. For instance, in 2016, Thermo Fisher expanded its Fisher BioServices and cryogenic service facilities in Japan.
Thermo Fisher Scientific, Merck KGaA, and GE Healthcare were Market Leaders in 2016
Key market players covered in this report are Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, GE Healthcare, Corning Incorporated, Becton, Dickinson and Company, Merck KGaA, Lonza, VWR International LLC, and PromoCell GmbH. Companies operating in the global market for cell culture are focusing on strategic collaborations for developing new products in emerging markets such as Asia Pacific and Latin America. For instance, in November 2016, GE Healthcare and Valneva SE announced a collaboration for optimizing virus productivity in Valneva’s EB66 cell line. Moreover, in May 2017, Merck announced the launch of EX-CELL Advanced HD perfusion mediums, which help increase the production and streamline the regulatory compliances.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453